抗癌新特药英菲格拉替尼有什么副作用？国内纳入医保了吗？

A small molecule ATP-competitive tyrosine kinase inhibitor of FGFR, used to treat previously treated, unresectable locally advanced or metastatic cholangiocarcinoma, inducing tumor cell death by reducing cancer cell proliferation. The drug will be launched in the United States in May 2021. Today let’s take a closer look at the side effects of Infigratinib? Is it covered by domestic medical insurance?

Infigratinib is the second cholangiocarcinoma-targeted drug. It mainly targets cholangiocarcinoma with FGFR2 fusion gene mutations and can bring benefits in terms of progression-free survival and overall response rate. However, the drug also has side effects, including diarrhea, dry skin, nail toxicity, stomatitis, alopecia, palmoplantar erythema syndrome, joint pain, dysgeusia, constipation, abdominal pain, dry mouth, eyelash changes, loss of appetite, dry eye syndrome, fatigue, blurred vision and vomiting. Patients should pay more attention to their own reactions during medication. Different conditions and constitutions have different side effects. If the patient develops intolerable toxicity, he or she can contact the doctor promptly for symptomatic treatment and a new treatment plan.

So, has the new anti-cancer drug Infigratinib been included in domestic medical insurance? Currently, the drug is not available in China, and patients cannot buy it in domestic hospital pharmacies, let alone reimbursement by medical insurance. Patients in need can obtain Infigratinib through Medical Companion Travel, which is cost-effective and affordable. Medical Companion Travel has cooperated with many domestic patients and is deeply trusted. It obtains overseas drugs through Medical Companion Travel. It is directly mailed by the pharmaceutical factory and is guaranteed to be authentic. It is suitable for patients to take medicine for a long time. Patients can consult the medical companion passenger service staff for specific drug prices and drug purchase procedures.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles: